Table 4.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
---|---|---|---|---|---|---|---|---|---|
R/N | KEN-DRG code | AR-DRG code | KEN-DRG description | LOS by KEN-DRG (days) | KEN-DRG price | Real cost based on ALOS | Base price | AR-DRG relative weights | Proposed DRG price |
1 | Π40Χ | G60B | Digestive malignancy W/O catastrophic CC | 3 | €600 | €1520 | €2045 | 0.87 | €1779 |
2 | Σ20Μ | R60A | Acute leukaemia W catastrophic CC | 17 | €5707 | €11,225 | €2045 | 7.1 | €14,520 |
3 | Σ21Μ | R61A | Lymphoma and non-acute leukaemia W catastrophic CC | 14 | €3100 | €6971 | €2045 | 4.86 | €9939 |
4 | Σ21Χ | R61B | Lymphoma and non-acute leukaemia W/O catastrophic CC | 5 | €1410 | €1462 | €2045 | 1.83 | €3742 |
5 | Α31Χ | E71B | Respiratory neoplasms W/O catastrophic CC | 5 | €828 | €2826 | €2045 | 1.17 | €2393 |
6 | Η41Χ | H61B | Malignancy of hepatobiliary system, pancreas W/O catastrophic CC | 4 | €792 | €1350 | €2045 | 1.12 | €2290 |
7 | Η41Μ | H61A | Malignancy of hepatobiliary system, pancreas W catastrophic CC | 9 | €1754 | €3266 | €2045 | 2.48 | €5072 |
8 | Σ22Χ | R62B | Other neoplastic disorders W/O CC | 2 | €638 | €1020 | €2045 | 0.82 | €1677 |
9 | Π40Μ | G60A | Digestive malignancy W catastrophic CC | 10 | €1100 | €4971 | €2045 | 2.15 | €4397 |
10 | Α31Μ | E71A | Respiratory neoplasms W catastrophic CC | 9 | €1634 | €4369 | €2045 | 2.31 | €4724 |
11 | Υ22Μ | L62A | Kidney and urinary tract neoplasms W catastrophic or severe CC | 7 | €1373 | €4672 | €2045 | 1.89 | €3865 |
12 | Σ01Μ | R01A | Lymphoma and leukaemia W major OR procedures W catastrophic or severe CC | 23 | €8000 | €12,790 | €2045 | 9.96 | €20,369 |
13 | Γ20Χ | N60B | Malignancy, female reproductive system W/O catastrophic CC | 4 | €1100 | €1843 | €2045 | 0.97 | €1984 |
ALOS average length of stay, AR-DRG Australian DRG system, CC Catastrophic or Severe CC, DRG diagnosis-related group, KEN-DRG Greek diagnosis-related group, LOS length of stay, R/N row number, W with, W/O without